dc.contributor.author | Vopálenský, Václav | |
dc.contributor.author | Sýkora, Michal | |
dc.contributor.author | Mělková, Zora | |
dc.contributor.author | Barvík, Ivan | |
dc.contributor.author | Mašek, Tomáš | |
dc.contributor.author | Horáčková, Kamila | |
dc.contributor.author | Pospíšek, Martin | |
dc.date.accessioned | 2023-08-25T10:40:23Z | |
dc.date.available | 2023-08-25T10:40:23Z | |
dc.date.issued | 2023 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14178/2006 | |
dc.description.abstract | Vaccinia virus (VACV) is a prototypical poxvirus originally used for eradication of smallpox. Investigation into VACV mRNAs carried out almost half a century agosubstantially contributed to the fundamental discovery of the 5' mRNA cap, a hallmark of all eukaryotic and many viral mRNAs. VACV research also facilitated the identification and understanding of the general mechanism of 5' mRNA capsynthesis. We characterized the VACV transcripts at the individual mRNA molecule level and found that vaccinia postreplicative mRNAs, containing nontemplated 5' poly(A) leaders, surprisingly lack the 5' cap structure in vivo. We showing that 5' cap occurrence in viral mRNAs gradually decreases in eachsuccessive gene time classes, in contrast to the reciprocal increase in 5' poly(A)leader lengths, and that these two variables are mutually negatively correlated. Wealso demonstrate that the initiator region element (INR) directly or indirectlyinuences both the frequency of 5' mRNA capping and the occurrence of 5'poly(A) leaders, including their lengths in postreplicative VACV mRNAs. | en |
dc.language.iso | en | |
dc.rights | Creative Commons Uveďte původ 4.0 International | cs |
dc.rights | Creative Commons Attribution 4.0 International | en |
dc.title | Transcripts of vaccinia virus postreplicative genes do not contain a 5' methylguanosine cap | en |
dcterms.accessRights | openAccess | |
dcterms.license | https://creativecommons.org/licenses/by/4.0/legalcode | |
dc.date.updated | 2025-01-15T10:11:47Z | |
dc.subject.keyword | Vaccinia | en |
dc.subject.keyword | RNA | en |
dc.subject.keyword | VACV transcript | en |
dc.relation.fundingReference | info:eu-repo/grantAgreement/MSM//LX22NPO5103 | |
dc.relation.fundingReference | info:eu-repo/grantAgreement/GA0/GA/GA21-25504S | |
dc.relation.fundingReference | info:eu-repo/grantAgreement/GA0/GA/GA21-25504S | |
dc.date.embargoStartDate | 2025-01-15 | |
dc.contributor.organizer | RNA Society | |
dc.type.obd | 110 | |
dc.type.version | info:eu-repo/semantics/acceptedVersion | |
dc.identifier.obd | 633859 | |
dc.identifier.riv | RIV/00216208:11310/23:10466199 | |
dc.subject.rivPrimary | 10000::10600 | |
dcterms.isPartOf.name | The 28th Annual Meeting of the RNA Society | |
dcterms.isPartOf.journalYear | 2023 | |
uk.faculty.primaryId | 115 | |
uk.faculty.primaryName | Přírodovědecká fakulta | cs |
uk.faculty.primaryName | Faculty of Science | en |
uk.faculty.secondaryId | 108 | |
uk.faculty.secondaryId | 116 | |
uk.faculty.secondaryName | 1. lékařská fakulta | cs |
uk.faculty.secondaryName | First Faculty of Medicine | en |
uk.faculty.secondaryName | Matematicko-fyzikální fakulta | cs |
uk.faculty.secondaryName | Faculty of Mathematics and Physics | en |
uk.department.primaryId | 1034 | |
uk.department.primaryName | Katedra genetiky a mikrobiologie | cs |
uk.department.primaryName | Department of Genetics and Microbiology | en |
uk.department.secondaryId | 1191 | |
uk.department.secondaryId | 1539 | |
uk.department.secondaryName | Fyzikální ústav UK | cs |
uk.department.secondaryName | Institute of Physics of Charles University | en |
uk.department.secondaryName | Ústav lékařské mikrobiologie 1. LF UK a VFN | cs |
uk.department.secondaryName | Institute of Medical Microbiology | en |
uk.event.name | The 28th Annual Meeting of the RNA Society | |
dc.type.obdHierarchyCs | ABSTRAKT::abstrakt::abstrakt v elektronické podobě | cs |
dc.type.obdHierarchyEn | ABSTRACT::abstract::abstract in e-form | en |
dc.type.obdHierarchyCode | 110::130::136 | en |
uk.displayTitle | Transcripts of vaccinia virus postreplicative genes do not contain a 5' methylguanosine cap | en |